The global cellular health screening market was valued at USD 2.78 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. This growth is anticipated to be driven by an increasing focus on precision medicine, particularly the growing need for analyzing biomarkers associated with aging and overall cellular health. Cellular health screening...